What is Gugulipid®

Gugulipid® is a registered trademark (Registration date : July 21, 1992) of Sabinsa Corporation.  Sabinsa introduced Gugulipid® to the U.S. market in 1990.

Gugulipid® is a standardized extract prepared from the oleogum resin (gum resin) of Commiphora mukul, an Indian medicinal tree that has been clinically proven to reduce the levels of harmful serum lipids in the bloodstream. The active ingredients responsible for the maintenance of healthy cholesterol levels are the guggulsterones, specifically guggulsterone E and guggulsterone Z.

 

"These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, cure, or prevent any disease"
 

Copyright © Sabinsa Corporation. All Rights Reserved | Disclaimer

Disclaimer
×

US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.